chr17-63601175-AC-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_016360.4(TACO1):βc.97delCβ(p.Arg33fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000317 in 1,547,066 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ).
Frequency
Genomes: π 0.000026 ( 0 hom., cov: 32)
Exomes π: 0.000032 ( 0 hom. )
Consequence
TACO1
NM_016360.4 frameshift
NM_016360.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.123
Genes affected
TACO1 (HGNC:24316): (translational activator of cytochrome c oxidase I) This gene encodes a mitochondrial protein that function as a translational activator of mitochondrially-encoded cytochrome c oxidase 1. Mutations in this gene are associated with Leigh syndrome.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.891 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-63601175-AC-A is Pathogenic according to our data. Variant chr17-63601175-AC-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 818073.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TACO1 | ENST00000258975.7 | c.97delC | p.Arg33fs | frameshift_variant | 1/5 | 1 | NM_016360.4 | ENSP00000258975.6 | ||
ENSG00000288894 | ENST00000690765.1 | n.*107-3354delC | intron_variant | ENSP00000510085.1 | ||||||
TACO1 | ENST00000684587.1 | c.97delC | p.Arg33fs | frameshift_variant | 1/5 | ENSP00000507435.1 | ||||
TACO1 | ENST00000581120.1 | n.299delC | non_coding_transcript_exon_variant | 1/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000265 AC: 4AN: 151046Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
151046
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000684 AC: 1AN: 146110Hom.: 0 AF XY: 0.0000126 AC XY: 1AN XY: 79408
GnomAD3 exomes
AF:
AC:
1
AN:
146110
Hom.:
AF XY:
AC XY:
1
AN XY:
79408
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000322 AC: 45AN: 1396020Hom.: 0 Cov.: 31 AF XY: 0.0000291 AC XY: 20AN XY: 688404
GnomAD4 exome
AF:
AC:
45
AN:
1396020
Hom.:
Cov.:
31
AF XY:
AC XY:
20
AN XY:
688404
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000265 AC: 4AN: 151046Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73738
GnomAD4 genome
AF:
AC:
4
AN:
151046
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
73738
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Mitochondrial complex 4 deficiency, nuclear type 8 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 21, 2024 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 15, 2022 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at